Innovent and GenFleet Announce Exclusive Global License Agre

Innovent and GenFleet Announce Exclusive Global License Agreement for GFH925 (KRAS G12C Inhibitor)

Innovent and GenFleet Announce Exclusive Global License Agreement for GFH925 (KRAS G12C Inhibitor)

prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Taiwan , Shanghai , China , United States , Hong Kong , Suzhou , Jiangsu , Guangdong , Jilin , Macau , Adimab Incyte , Yongjun Liu , Eli Lilly , Yilong Wu , Prnewswire Innovent Biologics Inc , Md Anderson Cancer Center , Guangdong Lung Cancer Institute , National Medical Products Administration , Shanghai Inc , Incyte Corporation , Innovent Biologics Inc , Genfleet Therapeutics , Investigational New Drug , New Drug Application , Jiong Lan , Main Board , Stock Exchange , Hong Kong Limited , Biologics License Application , Cancer Center , Mainland China ,